Skip to content

Palvella Therapeutics

US · PVLA #2822 by market cap Listed 1970
142.85 -2.92 -2.00%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Palvella Therapeutics

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Founded
2015
CEO
Mr. Wesley H. Kaupinen
Employees
29
Headquarters
Wayne, Pennsylvania, United States of America
Fiscal year end
12-31
Website
palvellatx.com

Company profile

Exchange
US
Symbol
PVLA
Market-cap rank
#2822
Listing date
1970-01-01
Market cap
2.09B
Float cap
1.57B
Shares out
14.62M
Float shares
11.01M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Palvella Therapeutics discussion 0 comments

Add a comment